Understanding NAFLD and NASH

Guest blog by: Monica Morgan, Pharm.D., CSP As a specialty pharmacy that works with many patients during treatment for liver diseases, it’s not surprising that questions about nonalcoholic fatty liver disease (NAFLD) come up in our line of work. Although hepatitis C is our primary liver focus, both hepatitis C and NAFLD rank as the…

Coffee: Pour Another Cup, Guilt-Free

Coffee is not only a welcome way that 54% of Americans start their day, it also offers liver benefits to coffee fans. I have shared good news about coffee and liver health in several past blogs, including last year’s The Buzz of Caffeine in which coffee’s ability to protect against liver cancer was discussed. Now…

Longevity After Hepatitis C Treatment

Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, over the past few years the newly available treatment options now mean that more than 90% of patients with hepatitis C can be cured of…

The Changing Face of Liver Cancer

Hepatitis C infections get a lot of bad press when it comes to liver cancer. While it is true that hepatitis C is a significant risk factor for liver cancer, there is another risk factor that is even more risky: metabolic disorders. In fact, new research just found that metabolic disorders are the number one…

Get Screened, Get Treated, Save Lives

New options in treating – and curing – almost all cases of hepatitis C infection have been cause for celebration over the past few years. Yet, this is not the time to let our guard down. Recently the Annual Report to the Nation on the Status of Cancer, which is a joint project from the…

The Hepatitis C-Parkinson’s Disease Link

An estimated 3.5 million Americans have chronic hepatitis C virus (HCV) infection, a contagious liver disease that can lead to cirrhosis and/or liver cancer. Meanwhile, an estimated one million Americans live with the progressive movement disorder of Parkinson’s disease. For the first time, research indicates that these two conditions could be linked. With Parkinson’s disease,…

The True Cost

Infection with the hepatitis C virus (HCV) remains a leading cause of liver cancer in the United States. Treatments now available for HCV can cure upwards of 90% of patients; however, the high price tag of these HCV treatments can serve as an obstacle to these medications reaching all infected people. Yet, there is a…

More Reason than Ever to Start Treatment

Chronic infection with the hepatitis C virus (HCV) primarily harms the liver, with liver cancer being a well-known consequence in some individuals – especially those who already have cirrhosis. Yet evidence continues to mount indicating that HCV also increases the risk of other, non-liver cancers. At the 50th International Liver Congress hosted by the European…

Timely Treatment

When one analyzes the medical records of 1.6 American adults, it turns out there’s a lot to be learned there. Researchers with the Chronic Hepatitis Cohort Study (CHeCS) did just that starting back in 2006 and tracked the ongoing health of those with hepatitis for the next numerous years. As the CHeCS researchers uncovered connections…

World Hepatitis Day

One of the key messages of today July 28th, World Hepatitis Day, is simply this: hepatitis C is a preventable and treatable disease. The World Health Organization created World Hepatitis Day to raise awareness about the massive number of people already infected with one of several hepatitis viruses, including the hepatitis C, and how anyone…

The Buzz of Caffeine

Coffee brings a variety of health benefits. For the sake of your liver, it’s not just coffee but any form of caffeine that provides a “perk,” so to speak. Readers might recall several of my past blogs touching on the benefits of coffee for those with hepatitis C. Past research shows that coffee slows disease…